Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boehringer ingelheim
clinical trials
eli lilly
empagliflozin
europe
europe blog main
europe top stories
fda
indiana blog main
indiana top stories
insider
life sciences
national blog main
new york blog main
new york top stories
news
product launches
slgt2 inhibitor
type 1 diabetes
type 2 diabetes
What
bid
2
×
drug
2
×
ahead
approval
best
boehringer
bring
choices
choose
company
consumer
database
diabetes
drugs
eli
expand
fallen
fda
finding
founded
help
increasing
industry
ingelheim
iodine
july
knowledge
launch
launched
lilly
marketed
medicines
medicine’s
patients
pharmaceutical
platform
public
really
rejects
results
Language
unset
Current search:
bid
×
drug
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@thenextweb.com
9 years ago
Iodine: A platform to help you choose the best medicines for you
